Search
Now showing items 1-1 of 1
Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics
(AJOL, 2022)
Sisonke is a multicentre, open-label, single-arm phase 3B vaccine implementation study of healthcare workers (HCWs) in South Africa, with prospective surveillance for 2 years. The primary endpoint is the rate of severe ...